IQVIA SOLUTIONS ASIA PTE. LTD.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Computer Processing and Data Preparation and Processing Services, Information Retrieval Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about IQVIA SOLUTIONS ASIA PTE. LTD.
Live alerts from global media, monitored by Business Radar
2025-03-06 (manilatimes.net)
SCIENTURE to commercially launch REZENOPY®, a life-saving opioid overdose emergency treatment through a collaboration with KINDEVA DRUG DELIVERY L.P. |
TAMPA, FL, March 06, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, is pleased to announce that its wholly owned subsidiary, Scienture, LLC ("Scienture"), has entered into a definitive agreement with SUMMIT BIOSCIENCES INC. (a wholly owned subsidiary of Kindeva Drug Delivery L.P. ("Kindeva")), for the exclusive U.S. rights to commercially launch REZENOPY® (naloxone HCl) Nasal Spray 10mg, an opioid antagonist that was approved by the FDA on April 19, 2024.
Read more
2025-02-27 (stocktitan.net)
Ironwood Pharmaceuticals Announces 50% Workforce Reduction Amid Mixed 2024 Financial Results | IRWD Stock News
Ironwood reports $351.4M revenue with strategic reorganization expected to save $55-60M annually, despite 15% decrease in LINZESS sales to $916.3M.
Read more
2025-02-13 (politykazdrowotna.com)
Neuca, Farmacol and PGF join forces on the wholesale market for the sale of drugs
Polish pharmaceutical distribution - a new organization of distribution companies. Goal: ensuring the safety of drug supply and medical devices.
Read more
2025-01-29 (selectscience.net)
IQVIA and NVIDIA collaborate to transform healthcare and life sciences through advanced agentic AI solutions
Discover how IQVIA and NVIDIA are leveraging generative AI to transform healthcare and life sciences. Their collaboration focuses on scalable, AI-powered solutions to accelerate research, improve workflows, and enhance patient outcomes.
Read more
2025-01-25 (jomfruland.net)
Investing for Good: Don't Miss These Top Picks in Humane Stocks!
Investing for Good: Don't Miss These Top Picks in Humane Stocks! - Jomfruland.net
Read more
2025-01-18 (mexicobusiness.news)
AWS Bets US$5 Billion on Mexico's Digital Future: AI Week
This week, AWS opens a new region in Mexico, Gen AI fuels chip demand, and Nvidia partners with IQVIA to advance AI in healthcare.
Read more
2025-01-18 (biglobe.ne.jp)
NVIDIA partners with industry leaders to advance genomics, drug discovery, and healthcare (January 17, 2025) |
IQVIA, Illumina, MayoClinic, and ArcInstitute leverage NVIDIA's AI and accelerated computing to transform the $10 trillion healthcare and... | BIGLOBE News
Read more![[JP Morgan] ‘NVIDIA’ partners with IQVIA, Illumina, and Mayo… Acceleration of AI-based new drug development < Zoom in on academic conferences < Text of article -](https://images.businessradar.com/articles/8577a832-f28f-4082-94ab-7439faca183b)
2025-01-15 (thebionews.net)
[JP Morgan] ‘NVIDIA’ partners with IQVIA, Illumina, and Mayo… Acceleration of AI-based new drug development < Zoom in on academic conferences < Text of article -
[The Bio Reporter Kang Jo-ah] Global semiconductor company NVIDIA announced IQ, the world's largest clinical trial service company, at the 43rd '2025 J.P. Morgan Healthcare Conference' held in San Francisco, USA on the 14th (local time). With IQVIA
Read more
2025-01-14 (scientific-computing.com)
Nvidia aims to advance genomics, drug discovery and healthcare with new partnership | Scientific Computing World
IQVIA, Illumina, Mayo Clinic and Arc Institute Harness Nvidia AI to transform the healthcare and life sciences industry
Read more
2025-01-13 (aithority.com)
IQVIA and NVIDIA Collaborate to Transform Healthcare and Life Sciences Through Advanced Agentic AI Solutions
IQVIA, a leading global provider of clinical research services, commercial insights, and healthcare intelligence.
Read more
2025-01-13 (globenewswire.com)
NVIDIA Partners With Industry Leaders to Advance Genomics, Drug Discovery and Healthcare
IQVIA, Illumina, Mayo Clinic and Arc Institute Harness NVIDIA AI and Accelerated Computing to Transform $10 Trillion Healthcare and Life Sciences Industry...
Read more
2025-01-11 (centerforbiosimilars.com)
Eye on Pharma: Korean Drugmakers’ Impact in Europe; New Denosumab, Eculizumab Deals
Korean drugmakers hold over 50% market share in the 6 best-selling biosimilar markets, 2 companies sign exclusive licensing partnership for a denosumab biosimilar, and 2 others join forces for an eculizumab biosimilar.
Read more